Piedmont Investment Advisors’s Innoviva INVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-17,147
Closed -$241K 1086
2019
Q1
$241K Buy
17,147
+1,015
+6% +$16.4K 0.01% 957
2018
Q4
$282K Buy
16,132
+449
+3% +$7.29K 0.01% 760
2018
Q3
$239K Sell
15,683
-395
-2% -$5.69K 0.01% 897
2018
Q2
$222K Buy
16,078
+1,280
+9% +$19.2K 0.01% 780
2018
Q1
$247K Sell
14,798
-299
-2% -$4.62K 0.01% 640
2017
Q4
$214K Sell
15,097
-1,101
-7% -$14.7K ﹤0.01% 689
2017
Q3
$229K Sell
16,198
-590
-4% -$7.8K ﹤0.01% 675
2017
Q2
$215K Buy
+16,788
New +$211K ﹤0.01% 676

Other funds holding INVA

Piedmont Investment Advisors's INVA Position: Q2 2019 in Review

Piedmont Investment Advisors sold out of Innoviva (INVA) in Q2 2019, closing a stake of 17,147 shares — an estimated $241K sold.

Piedmont Investment Advisors first reported a position in INVA in Q2 2017 and held it in 8 quarters. The position peaked at $282K in Q4 2018. 217 funds tracked by Wall St. Rank hold INVA as of Q2 2019.

  • Piedmont Investment Advisors reported no remaining Innoviva position as of Q2 2019 after selling out during the quarter.
  • Piedmont Investment Advisors sold 17,147 Innoviva shares in Q2 2019, an estimated $241K.
  • Piedmont Investment Advisors first reported a position in Innoviva in Q2 2017 and held it in 8 quarters.
  • Piedmont Investment Advisors's Innoviva position peaked at $282K in Q4 2018.
  • 217 funds tracked by Wall St. Rank held Innoviva as of Q2 2019.

Based on Piedmont Investment Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.